Schoeffter P, Hoyer D
Preclinical Research, Sandoz Ltd, Basel, Switzerland.
J Pharmacol Exp Ther. 1990 Jan;252(1):387-95.
The 5-hydroxytryptamine (5-HT) receptor mediating endothelium-dependent relaxation of pig coronary arteries was characterized using a variety of 5-HT receptor agonists and antagonists. Unrubbed (with endothelium preserved) rings precontracted by prostaglandin F2 alpha in the presence of ketanserin relaxed in an endothelium-dependent manner to 5-HT, 5-carboxamidotryptamine and 5-methoxytryptamine with about equal potency and efficacy. By comparison, bufotenine, 3-(dimethylamino)ethyl-N-methyl-1H-indole-5-methane sulfonamide, (-)-alpha-methyl-5-HT,N,N-dipropyl-5-carboxamidotryptamine and 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H indole were half-efficient and other drugs [in particular the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin] were inactive as agonists up to 0.1 mM. The effect of 5-carboxamidotryptamine was antagonized in an apparently competitive manner by 15 drugs. Among the most potent antagonists (mean pKB value) were the nonselective 5-HT receptor antagonists, methiothepin (7.30) and metergoline (6.86), the 5-HT1A/5-HT1D receptor ligand, 1-[2-(4-amino-phenyl)ethyl]-4-(3-trifluoromethylphenyl)-piperazine (7.02), the 5-HT1A/5-HT1B/5-HT1D receptor ligand, 7-trifluoromethyl-4-(4-methyl-1-piperazinyl)-pyrrolo[1,2,-a]quinoxaline 1 (6.73) and yohimbine (6.37). Selective ligands for 5-HT1A receptors were either inactive [8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide] or poorly active (spiperone, 4.44). Beta-adrenoceptor antagonists with affinity for 5-HT1A and 5-HT1B receptors weakly antagonized the effect of 5-carboxamidotryptamine (pKB values less than or equal to 5.32), as did the 5-HT1c/5-HT2 receptor antagonist, mesulergine (5.30) and the yohimbine isomer, corynanthine (4.85). Methysergide was clearly a noncompetitive antagonist.(ABSTRACT TRUNCATED AT 250 WORDS)
运用多种5-羟色胺(5-HT)受体激动剂和拮抗剂,对介导猪冠状动脉内皮依赖性舒张的5-HT受体进行了特性研究。在酮色林存在的情况下,用前列腺素F2α预收缩的未摩擦(保留内皮)血管环,对5-HT、5-羧基酰胺色胺和5-甲氧基色胺以内皮依赖性方式舒张,其效力和效能大致相当。相比之下,蟾蜍色胺、3-(二甲基氨基)乙基-N-甲基-1H-吲哚-5-甲磺酰胺、(-)-α-甲基-5-HT、N,N-二丙基-5-羧基酰胺色胺和5-甲氧基-3-(1,2,3,6-四氢-4-吡啶基)-1H吲哚的效力减半,而其他药物[特别是5-HT1A受体激动剂8-羟基-2-(二正丙基氨基)四氢化萘]在浓度高达0.1 mM时作为激动剂无活性。15种药物以明显竞争性方式拮抗5-羧基酰胺色胺的作用。最有效的拮抗剂(平均pKB值)包括非选择性5-HT受体拮抗剂甲硫哒嗪(7.30)和麦角苄酯(6.86)、5-HT1A/5-HT1D受体配体1-[2-(4-氨基苯基)乙基]-4-(3-三氟甲基苯基)-哌嗪(7.02)、5-HT1A/5-HT1B/5-HT1D受体配体七氟甲基-4-(4-甲基-1-哌嗪基)-吡咯并[1,2,-a]喹喔啉1(6.73)和育亨宾(6.37)。5-HT1A受体的选择性配体要么无活性[8-羟基-2-(二正丙基氨基)四氢化萘氢溴酸盐],要么活性较差(螺哌隆,4.44)。对5-HT1A和5-HT1B受体有亲和力的β-肾上腺素能受体拮抗剂对5-羧基酰胺色胺的作用拮抗作用较弱(pKB值小于或等于5.32),5-HT1c/5-HT2受体拮抗剂美舒麦角(5.30)和育亨宾异构体柯楠因(4.85)也是如此。甲基麦角新碱显然是一种非竞争性拮抗剂。(摘要截短于250字)